UPDATED May 20, 2024
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
RNXT | US$1.40 | -0.7% | -31.0% | US$32.8m | US$3.75 | PB19x | E66.0% | n/a | ||
VRCA | US$8.70 | -9.0% | 51.0% | US$367.8m | US$14.17 | PS41.4x | E65.9% | n/a | ||
ARQT | US$9.35 | 17.0% | -5.0% | US$1.1b | US$18.83 | PS10.2x | E65.9% | n/a | ||
EXAS | US$51.00 | -8.3% | -39.0% | US$9.3b | US$86.59 | PS3.7x | E65.9% | n/a | ||
CTXR | US$0.66 | -5.1% | -41.6% | US$117.1m | US$4.00 | PB1.5x | E65.8% | n/a | ||
ARCT | US$29.78 | 3.7% | 9.5% | US$802.0m | US$72.29 | PS6.4x | E65.8% | n/a | ||
RYTM | US$37.96 | -5.6% | 122.4% | US$2.3b | US$57.22 | PS25.2x | E65.6% | n/a | ||
CING | US$0.79 | -0.1% | -96.0% | US$4.8m | US$14.00 | PB1.5x | E65.6% | n/a | ||
VBIV | US$0.64 | 1.0% | -79.6% | US$18.1m | US$5.00 | PS2.1x | E65.6% | n/a | ||
RPHM | US$1.90 | 19.5% | -76.9% | US$58.5m | US$1.83 | PB0.8x | E65.4% | n/a | ||
ZVRA | US$4.69 | -4.1% | -16.8% | US$198.0m | US$19.00 | PS7.1x | E65.3% | n/a | ||
QNRX | US$0.77 | -3.1% | -86.6% | US$3.0m | US$5.80 | PB0.3x | E65.2% | n/a | ||
AXSM | US$77.58 | 2.6% | 4.0% | US$3.6b | US$123.56 | PS14.7x | E65.1% | n/a | ||
GERN | US$3.73 | -0.3% | 18.4% | US$2.3b | US$6.07 | PS4254.6x | E64.9% | n/a | ||
EVAX | US$3.72 | -1.3% | -78.1% | US$20.1m | US$11.75 | PS275.7x | E64.7% | n/a | ||
XERS | US$2.05 | 8.5% | -30.5% | US$293.5m | US$4.90 | PS1.8x | E64.6% | n/a | ||
MDGL | US$232.10 | 9.8% | -18.7% | US$4.7b | US$363.86 | PB5.8x | E64.3% | n/a | ||
ALNY | US$150.24 | 0.2% | -22.2% | US$18.9b | US$220.38 | PS9.5x | E64.2% | n/a | ||
CELZ | US$4.30 | -0.7% | -31.6% | US$6.0m | US$30.00 | PS648.2x | E64.1% | n/a | ||
LAB | US$2.58 | 4.0% | 6.2% | US$956.4m | US$3.58 | PS7.6x | E64.0% | n/a | ||
CRMD | US$5.05 | -4.7% | -1.6% | US$281.4m | US$13.00 | PB4.8x | E63.9% | n/a | ||
VRNA | US$12.78 | -7.9% | -40.1% | US$1.1b | US$34.29 | PB4.2x | E63.6% | n/a | ||
SYRS | US$5.61 | 10.9% | 43.8% | US$145.7m | US$19.25 | PS21.5x | E63.4% | n/a | ||
SCPH | US$4.04 | -7.1% | -63.7% | US$171.3m | US$19.50 | PS8.3x | E63.3% | n/a |